WT | APP/PS1 | |||
---|---|---|---|---|
FTS•B (mg/kg) | ||||
10 | 40 | |||
TLR3 (ng/mL) | 29.6 ± 1.6 | 21.7 ± 1.9## | 27.3 ± 1.7* | 29.8 ± 1.2** |
p-IRF3/IRF3 | 1.2 ± 0.1 | 0.8 ± 0.0## | 0.9 ± 0.1* | 0.9 ± 0.0* |
IFN-β (pg/mL) | 95.4 ± 7.0 | 51.5 ± 7.2### | 89.8 ± 15.4* | 90.7 ± 6.3*** |
JIP3 (ng/L) | 233.9 ± 41.7 | 379 ± 35.9## | 274.7 ± 57 | 219.9 ± 40.9** |
p-JNK/JNK | 5.3 ± 0.6 | 8.4 ± 1.0## | 5.3 ± 0.8* | 5.4 ± 0.6* |
p-APP/APP | 0.2 ± 0.0 | 0.4 ± 0.1## | 0.2 ± 0.1** | 0.3 ± 0.1** |
Aβ (mg/L) | 2.5 ± 0.2 | 3.0 ± 0.1# | 2.4 ± 0.2** | 2.3 ± 0.2** |
TNF-α (ng/L) | 132.6 ± 13.2 | 189.7 ± 22.6# | 101.5 ± 25.3** | 103 ± 17.7** |
IL-1β (ng/L) | 91 ± 6.1 | 124.9 ± 8.9# | 95.9 ± 4.9** | 87.8 ± 7.6** |
IL-6 (pg/mL) | 193.1 ± 8.9 | 223.7 ± 7.8# | 190.2 ± 7.5** | 177.9 ± 11.9** |
IL-8 (pg/mL) | 367.3 ± 23.2 | 471.8 ± 22.9## | 364.1 ± 37.8* | 310.3 ± 22.9*** |
IL-12 (ng/L) | 58.6 ± 6.5 | 82.3 ± 4.0## | 69.5 ± 3.5* | 67.2 ± 2.9* |